BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Amexdrug Corp. (AXRX) Subsidiary BioRx to Unveil Several New Product Offerings


7/8/2009 11:34:12 AM

BEVERLY HILLS, CA--(Marketwire - July 08, 2009) -

Amexdrug Corporation (OTCBB: AXRX) announced today that its subsidiary BioRX Pharmaceuticals, producer of the Sponix® line of health and wellness products, has reached the final development stage for several new innovative products aimed at addressing a number of common ailments and conditions. BioRX already produces highly effective treatments for thinning hair, antifungal lotions, nail gel, anti-aging treatments, skin lightening products, sunscreen, and more. Sponix® products are currently sold through hundreds of independent pharmacies as well as through major retailers such as CVS Pharmacies, Target, and Amazon.com, with distribution expected to reach 25,000 retailers by the end of the year. Shortly, the company plans to unveil four new topical treatments that it anticipates will generate strong sales growth: a gel with soporific properties designed to relax the user and function as a sleep aid, a second product for the spot reduction of fat and cellulite, a third created to reduce puffiness and dark circles around the eyes, and fourth, a day cream specially formulated to combat the effects of aging.

According to Mr. Jack Amin, President of Amexdrug, "Each of these new products has passed several levels of rigorous testing and has been specifically designed to answer recognized needs in the marketplace. We are operating in a dynamic, multi-billion dollar industry that presents tremendous opportunities for growth, and we are extremely optimistic that these new products will only enhance our already strong product line. Likewise, we strongly believe that our new offerings will contribute to and enhance both increased sales revenues as well as stronger profit margins, and we look forward to providing additional details as we reach further milestones."

About Amexdrug Corporation:

Amexdrug Corporation is a vertically integrated company operating in the highly lucrative pharmaceutical and cosmeceutical industries. Along with its subsidiaries Dermagen, Inc. and BioRX Pharmaceuticals, Amexdrug is engaged in the research and development, marketing, production and sale of over-the-counter (OTC) pharmaceuticals and cosmetics as well as the distribution of prescription and over-the-counter drugs. The Company has advanced manufacturing facilities as well as an extensive distribution network, allowing Amexdrug to integrate various phases of operations into one efficient business entity. For more about Amexdrug, go to our website at www.amexdrug.com.


Contact:
Mr. Jack Amin
President
310-855-0475
www.amexdrug.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES